Cutaneous leishmaniasis may be best treated with local therapy and simple wound care instead of potentially toxic systemic treatments, according to a study published in Clinical Infectious Diseases. The researchers found that 92% of patients treated with simple wound care had positive outcomes after 42 and 60 days, compared with 79% of patients treated with cryotherapy and intralesional antimony injections, and 60% of patients who received systemic therapy.

Related Summaries